Douglass Winthrop Advisors, LLC Amgen Inc Transaction History
Douglass Winthrop Advisors, LLC
- $4.96 Billion
- Q4 2024
A detailed history of Douglass Winthrop Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Douglass Winthrop Advisors, LLC holds 14,140 shares of AMGN stock, worth $4.44 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
14,140
Previous 14,240
0.7%
Holding current value
$4.44 Million
Previous $4.59 Million
19.68%
% of portfolio
0.07%
Previous 0.09%
Shares
29 transactions
Others Institutions Holding AMGN
# of Institutions
3,180Shares Held
419MCall Options Held
8.25MPut Options Held
6.39M-
Vanguard Group Inc Valley Forge, PA52.7MShares$16.5 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY46MShares$14.4 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.4MShares$9.23 Billion0.31% of portfolio
-
Morgan Stanley New York, NY14.6MShares$4.57 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA13.2MShares$4.14 Billion0.65% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $168B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...